Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Bioventus (BVS) Pension (2020)

Bioventus filings provide 1 years of Pension readings, the most recent being $29.2 million for Q4 2020.

On a quarterly basis, Pension changed N/A to $29.2 million in Q4 2020 year-over-year; TTM through Dec 2020 was $29.2 million, a N/A change, with the full-year FY2020 number at $29.2 million, changed N/A from a year prior.
Pension hit $29.2 million in Q4 2020 for Bioventus.
In the past five years, Pension ranged from a high of $29.2 million in Q4 2020 to a low of $29.2 million in Q4 2020.